ID   OXSR1_HUMAN             Reviewed;         527 AA.
AC   O95747; Q3LR53; Q7Z501; Q9UPQ1;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   15-MAR-2017, entry version 162.
DE   RecName: Full=Serine/threonine-protein kinase OSR1;
DE            EC=2.7.11.1;
DE   AltName: Full=Oxidative stress-responsive 1 protein;
GN   Name=OXSR1 {ECO:0000312|HGNC:HGNC:8508};
GN   Synonyms=KIAA1101 {ECO:0000312|EMBL:BAA83053.2},
GN   OSR1 {ECO:0000312|EMBL:BAA75674.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAA75674.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT ILE-304.
RC   TISSUE=Skeletal muscle {ECO:0000312|EMBL:BAA75674.1};
RX   PubMed=10083736; DOI=10.1007/s100380050121;
RA   Tamari M., Daigo Y., Nakamura Y.;
RT   "Isolation and characterization of a novel serine threonine kinase
RT   gene on chromosome 3p22-21.3.";
RL   J. Hum. Genet. 44:116-120(1999).
RN   [2] {ECO:0000312|EMBL:BAA83053.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000312|EMBL:BAA83053.2};
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAP97192.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-304 AND THR-425.
RG   NIEHS SNPs program;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000312|EMBL:AAH08726.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH08726.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAP97192.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 172-527.
RA   Ding J.B., Yu L., Gong R.M., Mao N.H., Han X.F., Zhao S.Y.;
RT   "Cloning and characterization of a novel human cDNA homologous to
RT   human DCHT mRNA.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   FUNCTION, AUTOPHOSPHORYLATION, ENZYME REGULATION, INTERACTION WITH
RP   PAK1, AND MUTAGENESIS OF LYS-46.
RX   PubMed=14707132; DOI=10.1074/jbc.M313562200;
RA   Chen W., Yazicioglu M., Cobb M.H.;
RT   "Characterization of OSR1, a member of the mammalian Ste20p/germinal
RT   center kinase subfamily.";
RL   J. Biol. Chem. 279:11129-11136(2004).
RN   [7]
RP   INTERACTION WITH RELL1; RELL2 AND RELT, AND MUTAGENESIS OF LYS-46.
RX   PubMed=16389068; DOI=10.1016/j.bbrc.2005.12.033;
RA   Cusick J.K., Xu L.-G., Bin L.-H., Han K.-J., Shu H.-B.;
RT   "Identification of RELT homologues that associate with RELT and are
RT   phosphorylated by OSR1.";
RL   Biochem. Biophys. Res. Commun. 340:535-543(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339 AND SER-427, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339 AND SER-347, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339 AND SER-427, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22361696; DOI=10.1016/j.jprot.2012.01.030;
RA   Stadler C., Hjelmare M., Neumann B., Jonasson K., Pepperkok R.,
RA   Uhlen M., Lundberg E.;
RT   "Systematic validation of antibody binding and protein subcellular
RT   localization using siRNA and confocal microscopy.";
RL   J. Proteomics 75:2236-2251(2012).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-310; SER-324; SER-325;
RP   SER-339 AND SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-304 AND SER-433.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Regulates downstream kinases in response to
CC       environmental stress. May also have a function in regulating the
CC       actin cytoskeleton. {ECO:0000269|PubMed:14707132,
CC       ECO:0000303|PubMed:14707132}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:14707132}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:14707132};
CC   -!- ENZYME REGULATION: By autophosphorylation on threonine.
CC       {ECO:0000269|PubMed:14707132}.
CC   -!- SUBUNIT: Binds to and phosphorylates PAK1. Interacts with chloride
CC       channel proteins SLC12A6 isoform 2, SLC12A1 and SLC12A2 but not
CC       with SLC12A4 and SLC12A7, possibly establishing sensor/signaling
CC       modules that initiate the cellular response to environmental
CC       stress. Binds to and phosphorylates RELL1, RELL2 AND RELT.
CC       {ECO:0000269|PubMed:14707132, ECO:0000269|PubMed:16389068}.
CC   -!- INTERACTION:
CC       Q9Y376:CAB39; NbExp=3; IntAct=EBI-620853, EBI-306905;
CC       Q8NC24:RELL2; NbExp=5; IntAct=EBI-620853, EBI-10269209;
CC       P55011:SLC12A2; NbExp=2; IntAct=EBI-620853, EBI-2801449;
CC       Q9H4A3:WNK1; NbExp=2; IntAct=EBI-620853, EBI-457907;
CC       Q96J92:WNK4; NbExp=11; IntAct=EBI-620853, EBI-766352;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22361696}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in all tissue examined.
CC       {ECO:0000269|PubMed:10083736}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAP97192.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA83053.2; Type=Frameshift; Positions=63; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/oxsr1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB017642; BAA75674.1; -; mRNA.
DR   EMBL; AB029024; BAA83053.2; ALT_FRAME; mRNA.
DR   EMBL; DQ201638; ABA27097.1; -; Genomic_DNA.
DR   EMBL; BC008726; AAH08726.1; -; mRNA.
DR   EMBL; AF087893; AAP97192.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2675.1; -.
DR   RefSeq; NP_005100.1; NM_005109.2.
DR   UniGene; Hs.475970; -.
DR   PDB; 2V3S; X-ray; 1.70 A; A/B=433-527.
DR   PDB; 2VWI; X-ray; 2.15 A; A/B/C/D=1-303.
DR   PDB; 3DAK; X-ray; 2.25 A; A/B/C/D=6-295.
DR   PDBsum; 2V3S; -.
DR   PDBsum; 2VWI; -.
DR   PDBsum; 3DAK; -.
DR   ProteinModelPortal; O95747; -.
DR   SMR; O95747; -.
DR   BioGrid; 115269; 32.
DR   DIP; DIP-34977N; -.
DR   IntAct; O95747; 12.
DR   MINT; MINT-5207465; -.
DR   STRING; 9606.ENSP00000311713; -.
DR   BindingDB; O95747; -.
DR   ChEMBL; CHEMBL1163104; -.
DR   GuidetoPHARMACOLOGY; 2132; -.
DR   iPTMnet; O95747; -.
DR   PhosphoSitePlus; O95747; -.
DR   SwissPalm; O95747; -.
DR   BioMuta; OXSR1; -.
DR   EPD; O95747; -.
DR   MaxQB; O95747; -.
DR   PaxDb; O95747; -.
DR   PeptideAtlas; O95747; -.
DR   PRIDE; O95747; -.
DR   DNASU; 9943; -.
DR   Ensembl; ENST00000311806; ENSP00000311713; ENSG00000172939.
DR   GeneID; 9943; -.
DR   KEGG; hsa:9943; -.
DR   UCSC; uc003chy.4; human.
DR   CTD; 9943; -.
DR   DisGeNET; 9943; -.
DR   GeneCards; OXSR1; -.
DR   HGNC; HGNC:8508; OXSR1.
DR   HPA; CAB017181; -.
DR   HPA; HPA008237; -.
DR   MIM; 604046; gene.
DR   neXtProt; NX_O95747; -.
DR   OpenTargets; ENSG00000172939; -.
DR   PharmGKB; PA134973207; -.
DR   eggNOG; KOG0582; Eukaryota.
DR   eggNOG; ENOG410XSWS; LUCA.
DR   GeneTree; ENSGT00860000133680; -.
DR   HOGENOM; HOG000234204; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; O95747; -.
DR   KO; K08835; -.
DR   OMA; EPCIATI; -.
DR   OrthoDB; EOG091G0AKO; -.
DR   PhylomeDB; O95747; -.
DR   TreeFam; TF105339; -.
DR   SignaLink; O95747; -.
DR   SIGNOR; O95747; -.
DR   ChiTaRS; OXSR1; human.
DR   EvolutionaryTrace; O95747; -.
DR   GeneWiki; OXSR1; -.
DR   GenomeRNAi; 9943; -.
DR   PRO; PR:O95747; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000172939; -.
DR   CleanEx; HS_OSR1; -.
DR   CleanEx; HS_OXSR1; -.
DR   ExpressionAtlas; O95747; baseline and differential.
DR   Genevisible; O95747; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0071476; P:cellular hypotonic response; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:1901017; P:negative regulation of potassium ion transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:2000687; P:negative regulation of rubidium ion transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR028749; Oxsr1.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   PANTHER; PTHR24361:SF435; PTHR24361:SF435; 1.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    527       Serine/threonine-protein kinase OSR1.
FT                                /FTId=PRO_0000086456.
FT   DOMAIN       17    291       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      23     31       ATP. {ECO:0000250|UniProtKB:Q9Z1W9,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   ACT_SITE    146    146       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:Q9Z1W9,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   BINDING      46     46       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159,
FT                                ECO:0000269|PubMed:14707132}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES     310    310       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     324    324       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     325    325       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     339    339       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     347    347       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     427    427       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   VARIANT     304    304       T -> I (in dbSNP:rs6599079).
FT                                {ECO:0000269|PubMed:10083736,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_023232.
FT   VARIANT     425    425       S -> T (in dbSNP:rs35295772).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025181.
FT   VARIANT     433    433       P -> S (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040969.
FT   MUTAGEN      46     46       K->A: Loss of autophosphorylation and
FT                                kinase activity.
FT                                {ECO:0000269|PubMed:14707132,
FT                                ECO:0000269|PubMed:16389068}.
FT   MUTAGEN      46     46       K->M: Loss of RELT, RELL1 and RELL2
FT                                phosphorylation. Retention of some
FT                                autophosphorylation activity may be due
FT                                to complex formation with other
FT                                endogenous kinases in the assay.
FT                                {ECO:0000269|PubMed:14707132,
FT                                ECO:0000269|PubMed:16389068}.
FT   CONFLICT    316    316       K -> R (in Ref. 5; AAP97192).
FT                                {ECO:0000305}.
FT   CONFLICT    325    325       S -> G (in Ref. 5; AAP97192).
FT                                {ECO:0000305}.
FT   CONFLICT    363    363       K -> R (in Ref. 5; AAP97192).
FT                                {ECO:0000305}.
FT   HELIX        14     16       {ECO:0000244|PDB:3DAK}.
FT   STRAND       18     24       {ECO:0000244|PDB:2VWI}.
FT   STRAND       31     35       {ECO:0000244|PDB:2VWI}.
FT   TURN         37     40       {ECO:0000244|PDB:2VWI}.
FT   STRAND       42     46       {ECO:0000244|PDB:2VWI}.
FT   TURN         50     54       {ECO:0000244|PDB:2VWI}.
FT   HELIX        57     65       {ECO:0000244|PDB:2VWI}.
FT   STRAND       78     86       {ECO:0000244|PDB:2VWI}.
FT   STRAND       88     93       {ECO:0000244|PDB:2VWI}.
FT   HELIX       100    109       {ECO:0000244|PDB:2VWI}.
FT   TURN        110    115       {ECO:0000244|PDB:2VWI}.
FT   HELIX       120    139       {ECO:0000244|PDB:2VWI}.
FT   HELIX       149    151       {ECO:0000244|PDB:2VWI}.
FT   STRAND      152    154       {ECO:0000244|PDB:2VWI}.
FT   STRAND      160    162       {ECO:0000244|PDB:2VWI}.
FT   HELIX       166    170       {ECO:0000244|PDB:2VWI}.
FT   HELIX       195    202       {ECO:0000244|PDB:2VWI}.
FT   HELIX       207    222       {ECO:0000244|PDB:2VWI}.
FT   TURN        226    229       {ECO:0000244|PDB:2VWI}.
FT   HELIX       232    234       {ECO:0000244|PDB:2VWI}.
FT   HELIX       235    240       {ECO:0000244|PDB:2VWI}.
FT   TURN        247    250       {ECO:0000244|PDB:3DAK}.
FT   HELIX       254    257       {ECO:0000244|PDB:3DAK}.
FT   HELIX       262    271       {ECO:0000244|PDB:2VWI}.
FT   HELIX       276    278       {ECO:0000244|PDB:2VWI}.
FT   HELIX       282    286       {ECO:0000244|PDB:2VWI}.
FT   HELIX       289    293       {ECO:0000244|PDB:3DAK}.
FT   STRAND      434    441       {ECO:0000244|PDB:2V3S}.
FT   STRAND      447    454       {ECO:0000244|PDB:2V3S}.
FT   TURN        456    458       {ECO:0000244|PDB:2V3S}.
FT   HELIX       461    470       {ECO:0000244|PDB:2V3S}.
FT   HELIX       476    478       {ECO:0000244|PDB:2V3S}.
FT   HELIX       479    491       {ECO:0000244|PDB:2V3S}.
FT   TURN        493    495       {ECO:0000244|PDB:2V3S}.
FT   STRAND      497    502       {ECO:0000244|PDB:2V3S}.
FT   HELIX       504    506       {ECO:0000244|PDB:2V3S}.
FT   STRAND      507    511       {ECO:0000244|PDB:2V3S}.
FT   HELIX       515    517       {ECO:0000244|PDB:2V3S}.
FT   STRAND      519    526       {ECO:0000244|PDB:2V3S}.
SQ   SEQUENCE   527 AA;  58022 MW;  B46EC934E95A3A1F CRC64;
     MSEDSSALPW SINRDDYELQ EVIGSGATAV VQAAYCAPKK EKVAIKRINL EKCQTSMDEL
     LKEIQAMSQC HHPNIVSYYT SFVVKDELWL VMKLLSGGSV LDIIKHIVAK GEHKSGVLDE
     STIATILREV LEGLEYLHKN GQIHRDVKAG NILLGEDGSV QIADFGVSAF LATGGDITRN
     KVRKTFVGTP CWMAPEVMEQ VRGYDFKADI WSFGITAIEL ATGAAPYHKY PPMKVLMLTL
     QNDPPSLETG VQDKEMLKKY GKSFRKMISL CLQKDPEKRP TAAELLRHKF FQKAKNKEFL
     QEKTLQRAPT ISERAKKVRR VPGSSGRLHK TEDGGWEWSD DEFDEESEEG KAAISQLRSP
     RVKESISNSE LFPTTDPVGT LLQVPEQISA HLPQPAGQIA TQPTQVSLPP TAEPAKTAQA
     LSSGSGSQET KIPISLVLRL RNSKKELNDI RFEFTPGRDT AEGVSQELIS AGLVDGRDLV
     IVAANLQKIV EEPQSNRSVT FKLASGVEGS DIPDDGKLIG FAQLSIS
//
